Diffusion-weighted imaging (b value = 1500 s/mm2) is useful to decrease false-positive breast cancer cases due to fibrocystic changes

Miho Ochi, Toshiro Kuroiwa, Shunya Sunami, Junji Murakami, Shinichiro Miyahara, Takashi Nagaie, Masafumi Oya, Hidetake Yabuuchi, Masamitsu Hatakenaka

Research output: Contribution to journalArticle

20 Citations (Scopus)

Abstract

Background: We aimed to evaluate the application of apparent diffusion coefficient (ADC) values calculated from diffusion-weighted imaging (DWI) (b value = 1500 s/mm2) in the breast imaging reporting and data system (BI-RADS). Methods: For 104 cases of breast lesions with definitive histology diagnosis (45 benign cases, 59 malignant cases) in which breast magnetic resonance imaging was performed, ADC values were compared between benign and malignant cases, between ductal carcinoma in situ (DCIS) and fibrocystic changes, and between DCIS and ductal hyperplasia (one type of fibrocystic change). Diagnostic accuracy was compared for a total of 101 images and for 34 images including only nine DCIS and 25 fibrocystic changes between BI-RADS alone (with categories 4a, 4b, and 5 defined as malignancies) and BI-RADS plus ADC. Results: There were significant differences in mean ADC values between malignant and benign cases (p < 0.0001) and between DCIS and fibrocystic changes (p < 0.002), but not between DCIS and ductal hyperplasia. Positive predictive values were significantly greater for BI-RADS plus ADC than for BI-RADS alone in all cases (70.5% for BI-RADS alone, 81.3% for BI-RADS plus ADC) and in cases of DCIS versus fibrocystic changes (40.9% for BI-RADS alone, 64.3% for BI-RADS plus ADC), resulting in a significant improvement in diagnostic accuracy with the addition of ADC. Conclusion: Adding ADC values calculated from DWI (b value = 1500 s/mm2) to BI-RADS is a useful way to improve differential diagnostic accuracy for malignant tumors and benign lesions, especially for DCIS versus fibrocystic changes, except in cases of ductal hyperplasia.

Original languageEnglish
Pages (from-to)137-144
Number of pages8
JournalBreast Cancer
Volume20
Issue number2
DOIs
Publication statusPublished - Apr 1 2013

Fingerprint

Information Systems
Carcinoma, Intraductal, Noninfiltrating
Breast
Breast Neoplasms
Fibrocystic Breast Disease
Hyperplasia
Neoplasms
Histology
Magnetic Resonance Imaging

All Science Journal Classification (ASJC) codes

  • Oncology
  • Radiology Nuclear Medicine and imaging
  • Pharmacology (medical)

Cite this

Diffusion-weighted imaging (b value = 1500 s/mm2) is useful to decrease false-positive breast cancer cases due to fibrocystic changes. / Ochi, Miho; Kuroiwa, Toshiro; Sunami, Shunya; Murakami, Junji; Miyahara, Shinichiro; Nagaie, Takashi; Oya, Masafumi; Yabuuchi, Hidetake; Hatakenaka, Masamitsu.

In: Breast Cancer, Vol. 20, No. 2, 01.04.2013, p. 137-144.

Research output: Contribution to journalArticle

Ochi, Miho ; Kuroiwa, Toshiro ; Sunami, Shunya ; Murakami, Junji ; Miyahara, Shinichiro ; Nagaie, Takashi ; Oya, Masafumi ; Yabuuchi, Hidetake ; Hatakenaka, Masamitsu. / Diffusion-weighted imaging (b value = 1500 s/mm2) is useful to decrease false-positive breast cancer cases due to fibrocystic changes. In: Breast Cancer. 2013 ; Vol. 20, No. 2. pp. 137-144.
@article{6a6fac5815f54ac3975dd8f9ef93566e,
title = "Diffusion-weighted imaging (b value = 1500 s/mm2) is useful to decrease false-positive breast cancer cases due to fibrocystic changes",
abstract = "Background: We aimed to evaluate the application of apparent diffusion coefficient (ADC) values calculated from diffusion-weighted imaging (DWI) (b value = 1500 s/mm2) in the breast imaging reporting and data system (BI-RADS). Methods: For 104 cases of breast lesions with definitive histology diagnosis (45 benign cases, 59 malignant cases) in which breast magnetic resonance imaging was performed, ADC values were compared between benign and malignant cases, between ductal carcinoma in situ (DCIS) and fibrocystic changes, and between DCIS and ductal hyperplasia (one type of fibrocystic change). Diagnostic accuracy was compared for a total of 101 images and for 34 images including only nine DCIS and 25 fibrocystic changes between BI-RADS alone (with categories 4a, 4b, and 5 defined as malignancies) and BI-RADS plus ADC. Results: There were significant differences in mean ADC values between malignant and benign cases (p < 0.0001) and between DCIS and fibrocystic changes (p < 0.002), but not between DCIS and ductal hyperplasia. Positive predictive values were significantly greater for BI-RADS plus ADC than for BI-RADS alone in all cases (70.5{\%} for BI-RADS alone, 81.3{\%} for BI-RADS plus ADC) and in cases of DCIS versus fibrocystic changes (40.9{\%} for BI-RADS alone, 64.3{\%} for BI-RADS plus ADC), resulting in a significant improvement in diagnostic accuracy with the addition of ADC. Conclusion: Adding ADC values calculated from DWI (b value = 1500 s/mm2) to BI-RADS is a useful way to improve differential diagnostic accuracy for malignant tumors and benign lesions, especially for DCIS versus fibrocystic changes, except in cases of ductal hyperplasia.",
author = "Miho Ochi and Toshiro Kuroiwa and Shunya Sunami and Junji Murakami and Shinichiro Miyahara and Takashi Nagaie and Masafumi Oya and Hidetake Yabuuchi and Masamitsu Hatakenaka",
year = "2013",
month = "4",
day = "1",
doi = "10.1007/s12282-011-0319-9",
language = "English",
volume = "20",
pages = "137--144",
journal = "Breast Cancer",
issn = "1340-6868",
publisher = "Springer Japan",
number = "2",

}

TY - JOUR

T1 - Diffusion-weighted imaging (b value = 1500 s/mm2) is useful to decrease false-positive breast cancer cases due to fibrocystic changes

AU - Ochi, Miho

AU - Kuroiwa, Toshiro

AU - Sunami, Shunya

AU - Murakami, Junji

AU - Miyahara, Shinichiro

AU - Nagaie, Takashi

AU - Oya, Masafumi

AU - Yabuuchi, Hidetake

AU - Hatakenaka, Masamitsu

PY - 2013/4/1

Y1 - 2013/4/1

N2 - Background: We aimed to evaluate the application of apparent diffusion coefficient (ADC) values calculated from diffusion-weighted imaging (DWI) (b value = 1500 s/mm2) in the breast imaging reporting and data system (BI-RADS). Methods: For 104 cases of breast lesions with definitive histology diagnosis (45 benign cases, 59 malignant cases) in which breast magnetic resonance imaging was performed, ADC values were compared between benign and malignant cases, between ductal carcinoma in situ (DCIS) and fibrocystic changes, and between DCIS and ductal hyperplasia (one type of fibrocystic change). Diagnostic accuracy was compared for a total of 101 images and for 34 images including only nine DCIS and 25 fibrocystic changes between BI-RADS alone (with categories 4a, 4b, and 5 defined as malignancies) and BI-RADS plus ADC. Results: There were significant differences in mean ADC values between malignant and benign cases (p < 0.0001) and between DCIS and fibrocystic changes (p < 0.002), but not between DCIS and ductal hyperplasia. Positive predictive values were significantly greater for BI-RADS plus ADC than for BI-RADS alone in all cases (70.5% for BI-RADS alone, 81.3% for BI-RADS plus ADC) and in cases of DCIS versus fibrocystic changes (40.9% for BI-RADS alone, 64.3% for BI-RADS plus ADC), resulting in a significant improvement in diagnostic accuracy with the addition of ADC. Conclusion: Adding ADC values calculated from DWI (b value = 1500 s/mm2) to BI-RADS is a useful way to improve differential diagnostic accuracy for malignant tumors and benign lesions, especially for DCIS versus fibrocystic changes, except in cases of ductal hyperplasia.

AB - Background: We aimed to evaluate the application of apparent diffusion coefficient (ADC) values calculated from diffusion-weighted imaging (DWI) (b value = 1500 s/mm2) in the breast imaging reporting and data system (BI-RADS). Methods: For 104 cases of breast lesions with definitive histology diagnosis (45 benign cases, 59 malignant cases) in which breast magnetic resonance imaging was performed, ADC values were compared between benign and malignant cases, between ductal carcinoma in situ (DCIS) and fibrocystic changes, and between DCIS and ductal hyperplasia (one type of fibrocystic change). Diagnostic accuracy was compared for a total of 101 images and for 34 images including only nine DCIS and 25 fibrocystic changes between BI-RADS alone (with categories 4a, 4b, and 5 defined as malignancies) and BI-RADS plus ADC. Results: There were significant differences in mean ADC values between malignant and benign cases (p < 0.0001) and between DCIS and fibrocystic changes (p < 0.002), but not between DCIS and ductal hyperplasia. Positive predictive values were significantly greater for BI-RADS plus ADC than for BI-RADS alone in all cases (70.5% for BI-RADS alone, 81.3% for BI-RADS plus ADC) and in cases of DCIS versus fibrocystic changes (40.9% for BI-RADS alone, 64.3% for BI-RADS plus ADC), resulting in a significant improvement in diagnostic accuracy with the addition of ADC. Conclusion: Adding ADC values calculated from DWI (b value = 1500 s/mm2) to BI-RADS is a useful way to improve differential diagnostic accuracy for malignant tumors and benign lesions, especially for DCIS versus fibrocystic changes, except in cases of ductal hyperplasia.

UR - http://www.scopus.com/inward/record.url?scp=84884763535&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84884763535&partnerID=8YFLogxK

U2 - 10.1007/s12282-011-0319-9

DO - 10.1007/s12282-011-0319-9

M3 - Article

C2 - 22161277

AN - SCOPUS:84884763535

VL - 20

SP - 137

EP - 144

JO - Breast Cancer

JF - Breast Cancer

SN - 1340-6868

IS - 2

ER -